SIDLEY AUSTIN LLP for COVIDIEN INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Energy/Nuclear ENG
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER M GOODLOE New | Legislative Counsel, House Energy & Commerce ; ; Legislative Counsel, House Office of Legislative Counsel |
| WILLIAM A SARRAILLE New | N/A |
| ANDREW W SHOYER New | Assistant General Counsel, USTR ; ; Legal Advisor, U.S. Mission to the WTO |
Pharmacy PHA
Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER M GOODLOE New | Legislative Counsel, House Energy & Commerce ; ; Legislative Counsel, House Office of Legislative Counsel |
| WILLIAM A SARRAILLE New | N/A |
| ANDREW W SHOYER New | Assistant General Counsel, USTR ; ; Legal Advisor, U.S. Mission to the WTO |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COVIDIEN PLC (ULTIMATE PARENT) | Ireland | Ireland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.